FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anthony Zietman

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Occupations

Radiation Oncology

Co-author Network

Publications

TOP 3
Anthony L Zietman
The Red Journal's Most Downloaded Articles of 2012.
John J Coen; Jason A Efstathiou; Niall M Heney; Donald S Kaufman; Andrzej Niemierko; Jonathan J Paly; Daphne Y Spiegel; Anthony L Zietman; William U Shipley
Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
Phillip J Gray; Stephen M Hahn; Daniel A Hamstra; Jeff M Michalski; Jonathan J Paly; Martin G Sanda; Howard M Sandler; William U Shipley; James A Talcott; Beow Y Yeap; Anthony L Zietman; Justin E Bekelman; John J Coen; Jason A Efstathiou
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anthony Zietman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anthony L Zietman
The Red Journal's Most Downloaded Articles of 2012.
International journal of radiation oncology, biology, physics 2013;86(2):218-21.
2013: John J Coen; Jason A Efstathiou; Niall M Heney; Donald S Kaufman; Andrzej Niemierko; Jonathan J Paly; Daphne Y Spiegel; Anthony L Zietman; William U Shipley
Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
International journal of radiation oncology, biology, physics 2013;86(2):311-6.
2013: Phillip J Gray; Stephen M Hahn; Daniel A Hamstra; Jeff M Michalski; Jonathan J Paly; Martin G Sanda; Howard M Sandler; William U Shipley; James A Talcott; Beow Y Yeap; Anthony L Zietman; Justin E Bekelman; John J Coen; Jason A Efstathiou
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.
Cancer 2013;119(9):1729-35.
2013: Phillip J Gray; Chun Chieh Lin; William U Shipley; Jason A Efstathiou; Stacey A Fedewa; Anthony L Zietman; Katherine S Virgo
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
European urology 2013;63(5):823-9.
2013: Jason A Efstathiou; P J Gray; Anthony L Zietman
Proton beam therapy and localised prostate cancer: current status and controversies.
British journal of cancer 2013;108(6):1225-30.
2013: Kent W Mouw; Alexei Trofimov; Anthony L Zietman; Jason A Efstathiou
Clinical controversies: proton therapy for prostate cancer.
Seminars in radiation oncology 2013;23(2):109-14.
2013: Timur Mitin; William U Shipley; Jason A Efstathiou; Niall M Heney; Donald S Kaufman; Richard J Lee; Anthony L Zietman
Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.
Current urology reports 2013;14(2):109-15.
2013: Anthony L Zietman; Gustavo A Viani
RETRACTED: High-dose conformal radiotherapy reduces prostate cancer-specific mortality: results of a meta-analysis Int J Radiat Oncol Biol Phys 2012;83:e619-e625.
International journal of radiation oncology, biology, physics 2013;85(4):899.
2013: Shereef M Elnahal; Richard S Helsper; John Kerstiens; Anthony L Zietman; Peter A S Johnstone
Proton beam therapy and accountable care: the challenges ahead.
International journal of radiation oncology, biology, physics 2013;85(4):e165-72.
2013: Jonathan J Paly; Anand Shah; William U Shipley; Anthony L Zietman; Justin E Bekelman; Peter W M Chung; Jason A Efstathiou; Mukesh Harisinghani; Sandeep S Hedgire; Martin O'Malley; Clair Beard
Mapping patterns of nodal metastases in seminoma: rethinking radiotherapy fields.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013;106(1):64-8.
2013: Paul E Wallner; Lynn D Wilson; Anthony L Zietman; K. Kian Ang; Jay R Harris; Geoffrey S Ibbott; Mary C Mahoney; Duane G Mezwa; Gary J Becker
The American Board of Radiology Holman Research Pathway: 10-year retrospective review of the program and participant performance.
International journal of radiation oncology, biology, physics 2013;85(1):29-34.
2012: Ayal A Aizer; Clair Beard; Anthony V D'Amico; Michelle S Hirsch; Irving D Kaplan; M Dror Michaelson; Paul Nguyen; Andrzej Niemierko; Aria F Olumi; Jonathan J Paly; Sandhya K Rao; Chin-Lee Wu; Anthony L Zietman; Jason A Efstathiou
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):3071-6.
2012: Hiram A Gay; Anuja Jhingran; Lisa A Kachnic; Colleen Lawton; W Robert Lee; Rawan Al-Lozi; H Joseph Barthold; Walter Bosch; Laura A Dawson; Issam El-Naqa; David Gaffney; Robert Myerson; Elizabeth O'Meara; Lorraine Portelance; Seth A Rosenthal; Janice Ryu; Howard Sandler; William Small; Akila N Viswanathan; Christopher Willett; Anthony L Zietman; Jeff M Michalski
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
International journal of radiation oncology, biology, physics 2012;83(3):e353-62.
2012: Anand Shah; William U Shipley; Neha Vapiwala; Anthony L Zietman; Deborah W Bruner; John P Christodouleas; John J Coen; Curtiland Deville; Jason A Efstathiou; Stephen M Hahn; Scott D Halpern; Jonathan J Paly; Justin E Bekelman
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2012;83(1):e13-9.
2012: William U Shipley; Anthony L Zietman
Old drugs, new purpose--bladder cancer turning a corner.
The New England journal of medicine 2012;366(16):1540-1.
2012: Jason A Efstathiou; Hsiao-Ming Lu; Maryam Moteabbed; Andrzej Niemierko; Judith A Adams; Basit S Athar; Justin E Bekelman; Jonathan J Paly; William U Shipley; Anthony L Zietman; Harald Paganetti
Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;103(1):12-7.
2012: Jason A Efstathiou; Niall M Heney; Donald S Kaufman; Francis J McGovern; Andrzej Niemierko; Jonathan J Paly; William U Shipley; Rafi Y Skowronski; Daphna Y Spiegel; John J Coen; Anthony L Zietman
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
European urology 2012;61(4):705-11.
2012: Donald S Kaufman; W Scott McDougal; Douglas M Dahl; Mukesh G Harisinghani; Anthony L Zietman; Chin-Lee Wu
Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level.
The New England journal of medicine 2012;366(12):1143-50.
2012: John J Coen; Andrzej Niemierko; Jonathan J Paly; Anita Rodrigues; William U Shipley; Elizabeth Weyman; Anthony L Zietman; James A Talcott
Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2012;82(2):e201-9.
2012: Philip J Saylor; Matthew R Smith; Anthony L Zietman; Marek A Ancukiewicz; Jason A Efstathiou; Rakesh K Jain; Kevin R Kozak; Dan G Duda
Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer.
The oncologist 2012;17(2):212-9.
2012: Brian J Davis; Peter D Grimm; Eric M Horwitz; W Robert Lee; Gregory S Merrick; Louis Potters; Richard G Stock; Nelson N Stone; Michael J Zelefsky; Anthony L Zietman; Wayne M Butler; Juanita M Crook
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
Brachytherapy 2012;11(1):6-19.
2011: John J Coen; Baldev Patel; William U Shipley; Jerry D Slater; Anthony L Zietman; Kyounghwa Bae; Carl J Rossi
Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: initial report of American College of Radiology Phase II study 03-12.
International journal of radiation oncology, biology, physics 2011;81(4):1005-9.
2011: Alexei Trofimov; Paul Nguyen; Jason A Efstathiou; Yi Wang; Hsiao-Ming Lu; Martijn Engelsman; Scott Merrick; Chee-Wai Cheng; James R Wong; Anthony L Zietman
Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2011;80(3):928-37.
2011: Matthew R Smith; Anthony L Zietman; Joel S Finkelstein; Chin-Lee Wu
Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
The New England journal of medicine 2011;364(21):2044-51.
2011: John J Coen; Adam S Feldman; Matthew R Smith; Anthony L Zietman
Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?
BJU international 2011;107(10):1582-6.
2011: Donald S Kaufman; Anthony L Zietman; Douglas M Dahl; Mukesh G Harisinghani; Chin-Lee Wu
Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.
The New England journal of medicine 2011;364(7):667-75.
2010: Min Zhang; John J Coen; Yoshiyuki Suzuki; Michael R Siedow; Andrzej Niemierko; Li-Yan Khor; Alan Pollack; Yifen Zhang; Anthony L Zietman; William U Shipley; Arnab Chakravarti
Survivin is a potential mediator of prostate cancer metastasis.
International journal of radiation oncology, biology, physics 2010;78(4):1095-103.
2010: Paul Nguyen; Ronald C Chen; Karen E Hoffman; Alexei Trofimov; Jason A Efstathiou; John J Coen; William U Shipley; Anthony L Zietman; James A Talcott
Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.
International journal of radiation oncology, biology, physics 2010;78(4):1081-5.
2010: James A Eastham; Christopher P Evans; Anthony L Zietman
What is the optimal management of high risk, clinically localized prostate cancer?
Urologic oncology 2010;28(5):557-67.
2010: Howard D Thames; Deborah A Kuban; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeffrey Michalski; Thomas M Pisansky; Howard Sandler; William Shipley; Michael J Zelefsky; Anthony L Zietman
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(1):6-12.
2010: Matthew S Katz; Jason A Efstathiou; Anthony V D'Amico; Michael W Kattan; Martin G Sanda; Paul L Nguyen; Matthew R Smith; Peter R Carroll; Anthony L Zietman
The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.
BJU international 2010;105(10):1417-22.
2010: James A Talcott; Carl Rossi; William U Shipley; Jack A Clark; Jerry D Slater; Andrzej Niemierko; Anthony L Zietman
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
JAMA : the journal of the American Medical Association 2010;303(11):1046-53.
2010: Jason A Efstathiou; William U Shipley; Anthony L Zietman; Matthew R Smith
Hormonal therapies: ADT for prostate cancer: true love or heartbreak?
Nature reviews. Clinical oncology 2010;7(3):130-2.
2010: Louis B Harrison; Anthony L Zietman
American society for radiation oncology intersociety summit summary.
International journal of radiation oncology, biology, physics 2010;76(3):643-8.
2010: Anthony L Zietman; Kyounghwa Bae; Jerry D Slater; William U Shipley; Jason A Efstathiou; John J Coen; David Bush; Margie Lunt; Daphna Y Spiegel; Rafi Skowronski; B Rodney Jabola; Carl J Rossi
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1106-11.
2010: Jeff M Michalski; Colleen Lawton; Issam El-Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard Valicenti; Anthony L Zietman; Walter Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
International journal of radiation oncology, biology, physics 2010;76(2):361-8.
2009: Grace Lu-Yao; Peter C Albertsen; Dirk Moore; Weichung Shih; Yong Lin; Robert S DiPaola; Michael J Barry; Anthony L Zietman; Michael O'Leary; Elizabeth Walker Corkery; Siu-Long Yao
Outcomes of localized prostate cancer following conservative management.
JAMA : the journal of the American Medical Association 2009;302(11):1202-9.
2009: Jason A Efstathiou; Alexei V Trofimov; Anthony L Zietman
Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer.
Cancer journal (Sudbury, Mass.) 2009;15(4):312-8.
2009: Robert W Ross; Anthony L Zietman; Wanling Xie; John J Coen; Douglas M Dahl; William U Shipley; Donald S Kaufman; Tina Islam; Alexander R Guimaraes; Ralph Weissleder; Mukesh G Harisinghani
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
Clinical imaging 2009;33(4):301-5.
2009: Jennifer Y Wo; William U Shipley; Douglas M Dahl; John J Coen; Niall M Heney; Donald S Kaufman; Anthony L Zietman
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
BJU international 2009;104(2):179-83.
2009: John J Coen; Anthony L Zietman
Proton radiation for localized prostate cancer.
Nature reviews. Urology 2009;6(6):324-30.
2009: Donald S Kaufman; Kathryn A Winter; William U Shipley; Niall M Heney; H James Wallace; Leonard M Toonkel; Anthony L Zietman; Simon Tanguay; Howard M Sandler
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Urology 2009;73(4):833-7.
2008: Raymond H Mak; Anthony L Zietman; Niall M Heney; Donald S Kaufman; William U Shipley
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
BJU international 2008;102(9 Pt B):1345-53.
2008: Scott Williams; Anthony L Zietman
Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy.
World journal of urology 2008;26(5):447-56.
2008: Jennifer Y Wo; Anthony L Zietman
Why does androgen deprivation enhance the results of radiation therapy?
Urologic oncology 2008;26(5):522-9.
2008: Jason A Efstathiou; Rafi Y Skowronski; John J Coen; Joseph A Grocela; Ariel E Hirsch; Anthony L Zietman
Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2008;71(5):1302-8.
2008: Anthony L Zietman
The future of radiation oncology: the evolution, diversification, and survival of the specialty.
Seminars in radiation oncology 2008;18(3):207-13.
2008: M Dror Michaelson; Shane E Cotter; Patricio C Gargollo; Anthony L Zietman; Douglas M Dahl; Matthew R Smith
Management of complications of prostate cancer treatment.
CA: a cancer journal for clinicians 2008;58(4):196-213.
2008: Paul Nguyen; Alexei Trofimov; Anthony L Zietman
Proton-beam vs intensity-modulated radiation therapy. Which is best for treating prostate cancer?
Oncology (Williston Park, N.Y.) 2008;22(7):748-54; discussion 754, 757.
2008: Matthew R Smith; Hang Lee; Francis J McGovern; Mary Anne Fallon; Melissa Goode; Anthony L Zietman; Joel S Finkelstein
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
Cancer 2008;112(10):2188-94.
2008: Anthony L Zietman
Active surveillance: a safe, low-cost prognostic test for prostate cancer.
BJU international 2008;101(9):1059-60.
2008: Anthony L Zietman
Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate.
JAMA : the journal of the American Medical Association 2008;299(8):898-9.
2008: Karen E Hoffman; Theodore S Hong; Anthony L Zietman; Anthony H Russell
External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
Cancer 2008;112(4):943-9.
2008: Subhash S John; Anthony L Zietman; William U Shipley; Mukesh G Harisinghani
Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
International journal of radiation oncology, biology, physics 2008;71(1 Suppl):S43-7.
2007: Alexei Trofimov; Paul Nguyen; John J Coen; Karen P Doppke; Robert J Schneider; Judith A Adams; Thomas Bortfeld; Anthony L Zietman; Thomas F DeLaney; William U Shipley
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
International journal of radiation oncology, biology, physics 2007;69(2):444-53.
2007: Paul Nguyen; Anthony L Zietman
High-dose external beam radiation for localized prostate cancer: current status and future challenges.
Cancer journal (Sudbury, Mass.) 2007;13(5):295-301.
2007: Anthony L Zietman
The Titanic and the Iceberg: prostate proton therapy and health care economics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3565-6.
2007: Donald S Kaufman; W Scott McDougal; Anthony L Zietman; Robert H Young
Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer.
The New England journal of medicine 2007;356(24):2515-20.
2007: Arndt-Christian Müller; Andrea Diestelhorst; Thomas Kuhnt; Reinhard Kühn; Paolo Fornara; Hans-Jörg Scholz; Jürgen Dunst; Anthony L Zietman
Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(4):177-83.
2007: Michael J Zelefsky; Deborah A Kuban; Lawrence B Levy; Louis Potters; David C Beyer; John C Blasko; Brian J Moran; Jay P Ciezki; Anthony L Zietman; Thomas M Pisansky; Mohamed A Elshaikh; Eric M Horwitz
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
International journal of radiation oncology, biology, physics 2007;67(2):327-33.
2007: Steven J Frank; Peter D Grimm; John E Sylvester; Gregory S Merrick; Brian J Davis; Anthony L Zietman; Brian J Moran; David C Beyer; Mack Roach; Daniel H Clarke; Richard G Stock; W Robert Lee; Jeff M Michalski; Kent E Wallner; Mark Hurwitz; Louis Potters; Deborah A Kuban; Bradley R Prestidge; Robyn Vera; Shannon Hathaway; John C Blasko
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Brachytherapy 2007;6(1):2-8.
2007: Michael Milosevic; Mary Gospodarowicz; Anthony L Zietman; Farhat Abbas; Karin Haustermans; Luc Moonen; Claus Rödel; Mark P Schoenberg; William Shipley
Radiotherapy for bladder cancer.
Urology 2007;69(1 Suppl):80-92.
2007: John J Coen; Anthony L Zietman; Donald S Kaufman; William U Shipley
Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.
Urologic oncology 2007;25(1):76-84.
2006: Henry K Tsai; Matthew Katz; John J Coen; Anthony L Zietman; Donald S Kaufman; William U Shipley
Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
Urology 2006;68(6):1188-92.
2006: Michael E Ray; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.
Urology 2006;68(6):1257-62.
2006: Jason A Efstathiou; Anthony L Zietman; Donald S Kaufman; Niall M Heney; John J Coen; William U Shipley
Bladder-sparing approaches to invasive disease.
World journal of urology 2006;24(5):517-29.
2006: Eric M Horwitz; Lawrence B Levy; Howard D Thames; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.
Cancer 2006;107(7):1496-502.
2006: Deborah A Kuban; Lawrence B Levy; Louis Potters; David C Beyer; John C Blasko; Brian J Moran; Jay P Ciezki; Anthony L Zietman; Michael J Zelefsky; Thomas M Pisansky; Mohamed A Elshaikh; Eric M Horwitz
Comparison of biochemical failure definitions for permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2006;65(5):1487-93.
2006: Howard D Thames; Deborah A Kuban; Michelle DeSilvio; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.
International journal of radiation oncology, biology, physics 2006;65(4):975-81.
2006: Michael E Ray; Howard D Thames; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
International journal of radiation oncology, biology, physics 2006;64(4):1140-50.
2005: Helen A Shih; Mukesh G Harisinghani; Anthony L Zietman; John A Wolfgang; Mansi A Saksena; Ralph Weissleder
Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
International journal of radiation oncology, biology, physics 2005;63(4):1262-9.
2005: Patrick A Kupelian; Howard D Thames; Larry Levy; Eric Horwitz; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2005;63(3):795-9.
2005: Joseph Grocela; Thomas Mauceri; Anthony L Zietman
New life after prostate brachytherapy? Considering the fertile female partner of the brachytherapy patient.
BJU international 2005;96(6):781-2.
2005: Anthony L Zietman; Michelle DeSilvio; Jerry D Slater; Carl J Rossi; Daniel W Miller; Judith A Adams; William U Shipley
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(10):1233-9.
2005: Min Zhang; Neelanjan Mukherjee; R Scott Bermudez; Douglas E Latham; Meaghan A Delaney; Anthony L Zietman; William U Shipley; Arnab Chakravarti
Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
The Prostate 2005;64(3):293-302.
2005: Anthony L Zietman; John P Christodouleas; William U Shipley
PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure.
International journal of radiation oncology, biology, physics 2005;62(3):714-8.
2005: Eric M Horwitz; Howard D Thames; Deborah A Kuban; Lawrence B Levy; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Gerald E Hanks; Anthony L Zietman
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
The Journal of urology 2005;173(3):797-802.
2005: Patrick A Kupelian; Deborah A Kuban; Howard D Thames; Larry Levy; Eric Horwitz; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
International journal of radiation oncology, biology, physics 2005;61(2):415-9.
2005: Deborah A Kuban; Howard D Thames; Larry Levy; Eric Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
International journal of radiation oncology, biology, physics 2005;61(2):409-14.
2005: Anthony L Zietman; Eila Skinner
Quality of life after radical treatment for invasive bladder cancer.
Seminars in radiation oncology 2005;15(1):55-9.
2005: William U Shipley; Anthony L Zietman; Donald S Kaufman; John J Coen; Howard M Sandler
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences.
Seminars in radiation oncology 2005;15(1):36-41.
2004: Brian G Czito; Anthony L Zietman; Donald Kaufman; Uri Skowronski; William U Shipley
Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
The Journal of urology 2004;172(4 Pt 1):1271-5.
2004: Michael J Zelefsky; Jennifer Moughan; Jean Owen; Anthony L Zietman; Mack Roach; Gerald E Hanks
Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(4):1053-61.
2004: Donald S Kaufman; W Scott McDougal; Anthony L Zietman; Mukesh G Harisinghani; Robert H Young
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2004. A 63-year-old man with metastatic prostate carcinoma refractory to hormone therapy.
The New England journal of medicine 2004;351(2):171-8.
2004: Matthew R Smith; Melissa Goode; Anthony L Zietman; Francis J McGovern; Hang Lee; Joel S Finkelstein
Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2546-53.
2004: M D Michaelson; William U Shipley; Niall M Heney; Anthony L Zietman; Donald S Kaufman
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.
British journal of cancer 2004;90(3):578-81.
2004: Anthony L Zietman; C S Chung; John J Coen; William U Shipley
10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study.
The Journal of urology 2004;171(1):210-4.
2003: Howard D Thames; Deborah A Kuban; Larry Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
International journal of radiation oncology, biology, physics 2003;57(4):929-43.
2003: Deborah A Kuban; Howard D Thames; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2003;57(4):915-28.
2003: Anthony L Zietman; Dianne Sacco; Uri Skowronski; Pablo Gomery; Donald S Kaufman; Jack A Clark; James A Talcott; William U Shipley
Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors.
The Journal of urology 2003;170(5):1772-6.
2003: Michael P Hagan; Kathryn A Winter; Donald S Kaufman; Zev Wajsman; Anthony L Zietman; Niall M Heney; Leonard M Toonkel; Christopher U Jones; John D Roberts; William U Shipley
RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
International journal of radiation oncology, biology, physics 2003;57(3):665-72.
2003: John J Coen; Christine S Chung; William U Shipley; Anthony L Zietman
Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis.
International journal of radiation oncology, biology, physics 2003;57(3):621-8.
2003: Alison M Friedmann; Esther Oliva; Anthony L Zietman; Suzanne L Aquino
Case records of the Massachusetts General Medicine. Weekly clinicopathological exercises. Case 9-2003. An 18-year-old man with back and leg pain and a nondiagnostic biopsy specimen.
The New England journal of medicine 2003;348(12):1150-8.
2003: Dianne Sacco; M Daller; Joseph Grocela; R K Babayan; Anthony L Zietman
Corticosteroid use after prostate brachytherapy reduces the risk of acute urinary retention.
BJU international 2003;91(4):345-9.
2003: John J Coen; Anthony L Zietman; William U Shipley
Prostatectomy or watchful waiting in prostate cancer.
The New England journal of medicine 2003;348(2):170-1; author reply 170-1.
2002: Anthony L Zietman
Dose escalation in localized prostate cancer: make no assumptions.
International journal of radiation oncology, biology, physics 2002;54(3):635-6.
2002: Mary McNaughton Collins; Michael J Barry; Anthony L Zietman; Peter C Albertsen; James A Talcott; Elizabeth Walker Corkery; Diana B Elliott; Floyd J Fowler
United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
Urology 2002;60(4):628-33.
2002: Torunn I Yock; Anthony L Zietman; William U Shipley; Harjot K Thakral; John J Coen
Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2002;54(2):420-6.
2002: Anthony L Zietman
Localized prostate cancer: brachytherapy.
Current treatment options in oncology 2002;3(5):429-36.
2002: John J Coen; Anthony L Zietman; Harjot K Thakral; William U Shipley
Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3199-205.
2002: Anthony L Zietman; Harjot K Thakral; Uri Skowronski; William U Shipley
Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy.
International journal of radiation oncology, biology, physics 2002;53(5):1152-9.
2002: William U Shipley; Donald S Kaufman; EM Zehr; Niall M Heney; S C Lane; Harjot K Thakral; AF Althausen; Anthony L Zietman
Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.
Urology 2002;60(1):62-7; discussion 67-8.
2002: Ashish K Chawla; Harjot K Thakral; Anthony L Zietman; William U Shipley
Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors.
Urology 2002;59(5):726-31.
2002: Matthew R Smith; Joel S Finkelstein; Francis J McGovern; Anthony L Zietman; Mary Anne Fallon; David Schoenfeld; Philip W Kantoff
Changes in body composition during androgen deprivation therapy for prostate cancer.
The Journal of clinical endocrinology and metabolism 2002;87(2):599-603.
2002: Anthony L Zietman; Christina T Smith
Neoadjuvant androgen suppression and external beam radiation therapy.
Frontiers of radiation therapy and oncology 2002;36():87-98.
2002: Anthony L Zietman
Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.
Frontiers of radiation therapy and oncology 2002;36():131-46.
2002: B G Gardner; Anthony L Zietman; William U Shipley; Uri Skowronski; P McManus
Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer.
The Journal of urology 2002;167(1):123-6.
2001: Anthony L Zietman; Harjot K Thakral; L Wilson; P Schellhammer
Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.
The Journal of urology 2001;166(5):1702-6.
2001: Matthew R Smith; Francis J McGovern; Anthony L Zietman; Mary Anne Fallon; D L Hayden; David Schoenfeld; Philip W Kantoff; Joel S Finkelstein
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
The New England journal of medicine 2001;345(13):948-55.
2001: Anthony L Zietman; Joseph Grocela; EM Zehr; Donald S Kaufman; Robert H Young; AF Althausen; Niall M Heney; William U Shipley
Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
Urology 2001;58(3):380-5.
2001: Anthony L Zietman; Jennifer Moughan; Jean Owen; Gerald Hanks
The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas.
International journal of radiation oncology, biology, physics 2001;50(1):75-80.
2000: Floyd J Fowler; Mary McNaughton Collins; Peter C Albertsen; Anthony L Zietman; Diana B Elliott; Michael J Barry
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 2000;283(24):3217-22.
2000: A Chakravatri; EM Zehr; Anthony L Zietman; William U Shipley; William Goggins; Dianne M Finkelstein; Robert H Young; E L Chang; Chin-Lee Wu
Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.
Urology 2000;55(5):635-8.
2000: Christopher G Willett; Choon Jin Ooi; Anthony L Zietman; V Menon; Saveli Goldberg; Bruce Sands; D K Podolsky
Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms.
International journal of radiation oncology, biology, physics 2000;46(4):995-8.
2000: Anthony L Zietman; William U Shipley; Donald S Kaufman
Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy.
Annals of medicine 2000;32(1):34-42.
1999: William U Shipley; Donald S Kaufman; Niall M Heney; AF Althausen; Anthony L Zietman
An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
The Journal of urology 1999;162(2):445-50; discussion 450-1.
1999: William U Shipley; H D Thames; H M Sandler; G E Hanks; Anthony L Zietman; C A Perez; D A Kuban; S L Hancock; C D Smith
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
JAMA : the journal of the American Medical Association 1999;281(17):1598-604.
1999: Anthony L Zietman; EM Zehr; William U Shipley
The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostate cancer.
International journal of radiation oncology, biology, physics 1999;43(4):715-8.
1998: Anthony L Zietman; William U Shipley; Donald S Kaufman; EM Zehr; Niall M Heney; AF Althausen; Francis J McGovern
A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
The Journal of urology 1998;160(5):1673-7.
1998: Anthony L Zietman
Radioactive seeds for prostate cancer.
Health news (Waltham, Mass.) 1998;4(13):4-5.
1998: Anthony L Zietman
Radiation therapy or prostatectomy: an old conflict revisited in the PSA era. A radiation oncologist's viewpoint.
Seminars in radiation oncology 1998;8(2):81-6.
1998: William U Shipley; Donald S Kaufman; Niall M Heney; AF Althausen; Anthony L Zietman
An update of selective bladder preservation by combined modality therapy for invasive bladder cancer.
European urology 1998;33 Suppl 4():32-4.
1997: Anthony L Zietman; J C Westgeest; William U Shipley
Radiation-based approaches to the management of T3 prostate cancer.
Seminars in urologic oncology 1997;15(4):230-8.
1997: William U Shipley; Anthony L Zietman; Donald S Kaufman; AF Althausen; Niall M Heney
Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation.
International journal of radiation oncology, biology, physics 1997;39(4):937-43.
1997: K E Kanady; William U Shipley; Anthony L Zietman; Donald S Kaufman; AF Althausen; Niall M Heney
Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer.
Seminars in surgical oncology 1997;13(5):359-64.
1997: Anthony L Zietman; William U Shipley; Niall M Heney; AF Althausen
The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.
Seminars in urologic oncology 1997;15(3):161-8.
1997: Anthony L Zietman; EA Prince; BM Nakfoor; J J Park
Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system.
International journal of radiation oncology, biology, physics 1997;38(5):1067-70.
1997: M M Morris; K C Dallow; Anthony L Zietman; J Park; AF Althausen; Niall M Heney; William U Shipley
Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer.
International journal of radiation oncology, biology, physics 1997;38(4):731-6.
1997: Anthony L Zietman; EA Prince; BM Nakfoor; William U Shipley
Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results.
Urology 1997;49(3A Suppl):74-83.
1997: Lisa A Kachnic; Donald S Kaufman; Niall M Heney; AF Althausen; P P Griffin; Anthony L Zietman; William U Shipley
Bladder preservation by combined modality therapy for invasive bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1022-9.
1997: Anthony L Zietman; BM Nakfoor; EA Prince; Leo E Gerweck
The effect of androgen deprivation and radiation therapy on an androgen-sensitive murine tumor: an in vitro and in vivo study.
The cancer journal from Scientific American 1997;3(1):31-6.
1996: K T Colvett; AF Althausen; B Bassil; Niall M Heney; F V McGovern; H H Young; Donald S Kaufman; Anthony L Zietman; William U Shipley
Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Journal of surgical oncology 1996;63(3):201-8.
1996: R M Douglas; Donald S Kaufman; Anthony L Zietman; AF Althausen; Niall M Heney; William U Shipley
Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer.
Seminars in oncology 1996;23(5):614-20.
1996: Anthony L Zietman; M K Tibbs; K C Dallow; C T Smith; AF Althausen; R A Zlotecki; William U Shipley
Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):159-62.
1996: M C Liu; Anthony L Zietman; William U Shipley
Organ preservation approaches with radiation therapy in muscle-invasive bladder carcinoma.
Annals of the Academy of Medicine, Singapore 1996;25(3):441-7.
1996: M A Fagundes; Anthony L Zietman; AF Althausen; J J Coen; William U Shipley
The management of spermatic cord sarcoma.
Cancer 1996;77(9):1873-6.
1996: Lisa A Kachnic; William U Shipley; P P Griffin; Anthony L Zietman; Donald S Kaufman; AF Althausen; Niall M Heney
Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
The cancer journal from Scientific American 1996;2(2):79-84.
1996: RA Edelstein; Anthony L Zietman; Antonio de las Morenas; Robert J Krane; Richard K Babayan; K C Dallow; Abdulmaged M Traish; Robert B Moreland
Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study.
Urology 1996;47(3):370-5.
1996: Anthony L Zietman; J J Coen; J A Ferry; Robert E Scully; Donald S Kaufman; F G McGovern
The management and outcome of stage IAE nonHodgkin's lymphoma of the testis.
The Journal of urology 1996;155(3):943-6.
1996: Anthony L Zietman; K C Dallow; P A McManus; Niall M Heney; William U Shipley
Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease.
Urology 1996;47(2):236-9.
1995: Anthony L Zietman; William U Shipley; Donald S Kaufman; D Esrig; B Lytton
Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
Contemporary urology 1995;7(7):23-4, 29, 32, passim.
1995: Anthony L Zietman; J J Coen; K C Dallow; William U Shipley
The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome.
International journal of radiation oncology, biology, physics 1995;32(2):287-92.
1995: William U Shipley; Lynn J Verhey; John E Munzenrider; Herman D Suit; M M Urie; P L McManus; Robert H Young; J W Shipley; Anthony L Zietman; Peter J Biggs
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
International journal of radiation oncology, biology, physics 1995;32(1):3-12.
1994: William U Shipley; Anthony L Zietman; Gerald E Hanks; J J Coen; R J Caplan; M Won; G K Zagars; S O Asbell
Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor.
The Journal of urology 1994;152(5 Pt 2):1799-805.
1994: Anthony L Zietman; William U Shipley; J J Coen
Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.
The Journal of urology 1994;152(5 Pt 2):1806-12.
1994: Barbara A Centeno; Anthony L Zietman; William U Shipley; M L Sobczak; J W Shipley; Frederic Preffer; B J Boyle; Robert Colvin
Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
International journal of radiation oncology, biology, physics 1994;30(2):309-15.
1994: Anthony L Zietman; RA Edelstein; J J Coen; Richard K Babayan; Robert J Krane
Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome.
Urology 1994;43(6):828-33.
1994: Christopher G Willett; Anthony L Zietman; William U Shipley; J J Coen
The effect of pelvic radiation therapy on serum levels of prostate specific antigen.
The Journal of urology 1994;151(6):1579-81.
1994: L E Gerweck; S T Zaidi; Anthony L Zietman
Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses.
International journal of radiation oncology, biology, physics 1994;29(1):57-66.
1994: Anthony L Zietman; J J Coen; William U Shipley; Christopher G Willett; J T Efird
Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
The Journal of urology 1994;151(3):640-5.
1994: BM Nakfoor; William U Shipley; Anthony L Zietman
Early stage testicular seminoma: the role of radiation therapy following orchiectomy.
Frontiers of radiation therapy and oncology 1994;28():183-95.
1993: Alphonse G Taghian; W Budach; Anthony L Zietman; J Freeman; D Gioioso; Herman D Suit
Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Cancer research 1993;53(20):5018-21.
1993: Alphonse G Taghian; W Budach; Anthony L Zietman; J Freeman; D Gioioso; W Ruka; Herman D Suit
Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Cancer research 1993;53(20):5012-7.
1993: Anthony L Zietman; William U Shipley; Donald S Kaufman
The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder.
International journal of radiation oncology, biology, physics 1993;27(1):161-70.
1993: Anthony L Zietman; J J Coen; William U Shipley; AF Althausen
Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure.
Urology 1993;42(3):292-8; discussion 298-9.
1993: Anthony L Zietman; William U Shipley; Christopher G Willett
Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications.
Cancer 1993;71(3 Suppl):959-69.
1991: Anthony L Zietman; R M Linggood; A R Brookes; K Convery; A Piro
Radiation therapy in the management of early stage Hodgkin's disease presenting in later life.
Cancer 1991;68(9):1869-73.
1991: Anthony L Zietman; E Sugiyama; J R Ramsay; V Silobrcic; E T Yeh; R S Sedlacek; Herman D Suit
A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies.
International journal of cancer. Journal international du cancer 1991;47(5):755-9.
1990: P Okunieff; M D Greenberg; Anthony L Zietman; J Kahn; S Westgate; L J Neuringer
Failure of 1H nuclear magnetic resonance spectroscopy of blood plasma to detect malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):906-10.
1990: P Okunieff; Anthony L Zietman; J Kahn; Samuel Singer; L J Neuringer; Robert A Levine; F E Evans
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
The New England journal of medicine 1990;322(14):953-8.
1990: Raymond Miralbell; Anthony L Zietman; P Okunieff; H D Thames; Herman D Suit
Fractionation sensitivity and immunological status in radiation treated murine sarcomas.
International journal of radiation oncology, biology, physics 1990;18(4):867-72.
1990: Anthony L Zietman; Herman D Suit; K N Tomkinson; H D Thames; R S Sedlacek
The response of two human tumor xenografts to fractionated irradiation. The derivation of alpha/beta ratios from growth delay, tumor control, and in vitro cell survival assays.
International journal of radiation oncology, biology, physics 1990;18(3):569-75.
1990: V Silobrcic; Anthony L Zietman; J R Ramsay; Herman D Suit; R S Sedlacek
Residual immunity of athymic NCr/Sed nude mice and the xenotransplantation of human tumors.
International journal of cancer. Journal international du cancer 1990;45(2):325-33.
1990: Herman D Suit; Anthony L Zietman; K Tomkinson; J Ramsay; L Gerweck; R Sedlacek
Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.
International journal of radiation oncology, biology, physics 1990;18(2):365-73.
1989: J Ramsay; Anthony L Zietman; Frederic Preffer; Herman D Suit
The growth and cell kinetics of a secondary tumor after radiation or surgical treatment of the primary tumor.
International journal of radiation oncology, biology, physics 1989;17(4):809-13.
1989: S Lauk; Anthony L Zietman; Steven J Skates; R Fabian; Herman D Suit
Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice.
Cancer research 1989;49(16):4557-61.
1988: Anthony L Zietman; Herman D Suit; J R Ramsay; V Silobrcic; R S Sedlacek
Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Cancer research 1988;48(22):6510-6.
1988: Herman D Suit; R S Sedlacek; Anthony L Zietman
Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice.
Cancer research 1988;48(16):4525-8.